ARCI backs enhanced NSAID and corticosteroid regs
Following a meeting on Monday, Aug. 5, the Drug Testing Standards and Practices (DTSP) Committee of the Association of Racing Commissions International (ARCI) endorsed instituting a 48-hour restriction on administration of nonsteroidal anti-inflammatory drugs (NSAIDS), which include Phenylbutazone, and a 14-day restriction on the administration of corticosteroids, pending scientific review.
The restriction on corticosteroids would not apply to harness racing, as the sport is currently amidst proceedings to determine breed-specific rules due to different race schedules for Thoroughbreds, Standardbreds and Quarter Horses.
The corticosteroids were previously included in the Model Rules but were removed per the instructions of the Racing Medication & Testing Consortium (RMTC). In a recent meeting of the RMTC, that organization recommended the 48-hour restriction on NSAIDs as the science is available to prove administration after that window can compromise a pre-race examination.
“There have been situations, specifically in New York, where these restrictions have been implemented and been quite successful,” said Ed Martin, ARCI president and past executive director of the New York Gaming and Wagering Board.
LATEST BUSINESS NEWS
Maryland Million 2024 has been set for October 12, 2024 at Laurel Park, the 38th edition of the day Jim McKay cofounded.
Delaware Park received approval Feb. 20 for its 2024 75-day live racing schedule, with the Delaware Handicap and Oaks anchoring the meet’s biggest weekend.
The Virginia Thoroughbred Association’s (VTA) annual stallion season auction will take place Feb. 14 and 15 and features dozens of exciting stallions.
The Maryland Racing Commission decided Tuesday it would fine people who appeal stewards’ decisions but no-show their appeals.
The economic impact of the Maryland horse industry reached nearly $3 billion in 2022, according to the American Horse Council.
The Horseracing Integrity and Safety Authority (HISA) will fund three studies on the use and impact of furosemide, also known as Lasix.